ClinicalTrials.Veeva

Menu

Matrilysin Expression in Different Stages of Colorectal Tumors (MMP7)

U

University of Roma La Sapienza

Status

Completed

Conditions

Colorectal Cancer Stage III
Colorectal Cancer Stage IV
Colorectal Cancer Stage II
Colorectal Cancer Stage I
Colorectal Cancer Stage 0

Treatments

Procedure: colonic or colorectal resection

Study type

Observational

Funder types

Other

Identifiers

NCT01570452
andreapolistena1

Details and patient eligibility

About

Matrix metalloproteinases (MMPs) have been shown to be involved in cancer biology. Significant expression of MMP-7 (matrilysin) in colorectal cancer is mainly associated with metastatic disease even though it is expressed in most tumor states. Our purpose is to analyse MMP-7 in bowel and lymph nodes of different tumor stages and to evaluate its expression as a potential biomarker of cancer disease in patients surgically treated for benign and malignant colorectal tumors. Tumoral tissue, lymph nodes and serum samples from recruited Patients plus serum samples from healthy volunteers are analysed for matrilysin expression by histology, immunohistochemistry, ELISA and Western blotting.

If Matrilysin increases with increasing dysplasia and cancer disease stage in tumor tissue as well as in the regional lymph nodes it might be used as a complement in investigating suspected locally advanced cancer.

Enrollment

38 patients

Sex

All

Ages

40 to 83 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • benign colonic neoplasm not suitable for endoscopic treatment,
  • malignant colonic neoplasm with indication to primary surgical treatment

Exclusion criteria

  • neo-adjuvant radiotherapy,
  • chemo-radiotherapy,
  • language problems and withdrawal of consent

Trial design

38 participants in 4 patient groups

healthy volunteers
Description:
healthy subjects not affected by benign or malignant colonic disease
Treatment:
Procedure: colonic or colorectal resection
benign colonic tumor patients
Description:
patients affected by benign colonic tumor such as adenoma
Treatment:
Procedure: colonic or colorectal resection
cancer patient I-II stage
Description:
Patients affected by colonic cancer in I-II stage
Treatment:
Procedure: colonic or colorectal resection
cancer patients III-IV stage
Description:
Patients affected by colonic cancer in III-IV stage
Treatment:
Procedure: colonic or colorectal resection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems